How the structural determinants of health inequities impact access to prescription medication for pregnant women in Australia: a narrative review.

Australia Equity Financing Health systems Maternal health Pharmaceutical preparations Policy

Journal

The Lancet regional health. Western Pacific
ISSN: 2666-6065
Titre abrégé: Lancet Reg Health West Pac
Pays: England
ID NLM: 101774968

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 02 07 2023
revised: 06 09 2023
accepted: 21 09 2023
medline: 15 2 2024
pubmed: 15 2 2024
entrez: 15 2 2024
Statut: epublish

Résumé

Structural factors that contribute to health disparities (e.g., population-level policies, cultural norms) impact the distribution of resources in society and can affect medication accessibility; even in high-income countries like Australia. Industry practices and regulatory approaches (e.g., a conservative approach to testing medicines in pregnant women) influence the availability of safety and efficacy data necessary for the licencing and funding of prescription medications used during pregnancy. Consequently, pregnant women may be prescribed medications outside of regulatory or funder-approved indications, posing risks for both prescribers and pregnant women and potentially compromising equitable access to medications. This review examines the regulatory and legislative structural factors that contribute to health disparities and perpetuate the deeply ingrained social norm that we should be protecting pregnant women Australian Government Research Training Program Stipend from the University of Technology Sydney, National Health and Medical Research Council (NHMRC) Fellowship, Channel 7 Children's Research Foundation Fellowship (CRF-210323).

Identifiants

pubmed: 38357390
doi: 10.1016/j.lanwpc.2023.100934
pii: S2666-6065(23)00252-3
pmc: PMC10865029
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100934

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

E.C. reports grants from Ferring Pharmaceuticals, outside the submitted work; and a role as Vice President of Women's Healthcare Australasia. No other authors have any conflicts of interest to disclose.

Auteurs

Hannah Jackson (H)

School of Public Health, Faculty of Health, University of Technology Sydney, New South Wales, Australia.

Luke Grzeskowiak (L)

College of Medicine and Public Health, Flinders University, South Australia, Australia.
SAHMRI Women and Kids, South Australian Health and Medical Research Institute, South Australia, Australia.

Joanne Enticott (J)

Monash Centre for Health Research and Implementation (MCHRI), Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.

Sarah Wise (S)

School of Public Health, Faculty of Health, University of Technology Sydney, New South Wales, Australia.

Emily Callander (E)

School of Public Health, Faculty of Health, University of Technology Sydney, New South Wales, Australia.

Classifications MeSH